全文获取类型
收费全文 | 1258篇 |
免费 | 140篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 20篇 |
妇产科学 | 43篇 |
基础医学 | 136篇 |
口腔科学 | 113篇 |
临床医学 | 136篇 |
内科学 | 342篇 |
皮肤病学 | 10篇 |
神经病学 | 73篇 |
特种医学 | 89篇 |
外科学 | 124篇 |
综合类 | 20篇 |
预防医学 | 130篇 |
眼科学 | 4篇 |
药学 | 124篇 |
肿瘤学 | 34篇 |
出版年
2023年 | 13篇 |
2021年 | 18篇 |
2020年 | 22篇 |
2019年 | 21篇 |
2018年 | 27篇 |
2017年 | 27篇 |
2016年 | 27篇 |
2015年 | 27篇 |
2014年 | 34篇 |
2013年 | 42篇 |
2012年 | 58篇 |
2011年 | 60篇 |
2010年 | 46篇 |
2009年 | 44篇 |
2008年 | 43篇 |
2007年 | 47篇 |
2006年 | 43篇 |
2005年 | 47篇 |
2004年 | 42篇 |
2003年 | 39篇 |
2002年 | 41篇 |
2001年 | 44篇 |
2000年 | 37篇 |
1999年 | 36篇 |
1998年 | 30篇 |
1997年 | 26篇 |
1996年 | 22篇 |
1995年 | 15篇 |
1994年 | 19篇 |
1993年 | 14篇 |
1992年 | 13篇 |
1991年 | 17篇 |
1990年 | 24篇 |
1989年 | 32篇 |
1988年 | 23篇 |
1987年 | 23篇 |
1986年 | 24篇 |
1985年 | 16篇 |
1984年 | 17篇 |
1983年 | 21篇 |
1982年 | 11篇 |
1981年 | 18篇 |
1980年 | 10篇 |
1979年 | 14篇 |
1978年 | 17篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 9篇 |
1974年 | 13篇 |
1972年 | 9篇 |
排序方式: 共有1401条查询结果,搜索用时 31 毫秒
21.
22.
23.
P. David Josephy Joban Dhanoa George Elzawy Kayla Heney Laurenne Petrie Chantel Senis 《Environmental and molecular mutagenesis》2018,59(2):114-122
2,6‐Dicyano‐4‐nitroaniline and 2‐cyano‐4‐nitroaniline (CNNA; 2‐amino‐5‐nitrobenzonitrile) are potent mutagens in the Ames test, even though unsubstituted nitroanilines (NAs) are no more than weak mutagens. These compounds are putative reduction products of many commercial azo dyes, including Disperse Blue 165, Disperse Blue 337, Disperse Red 73, Disperse Red 82, Disperse Violet 33, and Disperse Violet 63. We have examined the mutagenicity in strains TA98 and YG1024 of a series of commercially‐available isomers of CNNA, and some related compounds, to probe the relationship between structure and genotoxic activity in this class of compounds. The potentiating effect of the cyano substituent is seen in many cases; e.g. 2‐amino‐4‐nitrobenzonitrile is a much more potent mutagen than 3‐NA. 2,4‐Dinitrobenzonitrile is also highly mutagenic. Possible mechanisms for the “cyano effect” are considered, with respect to the likely structures of cyanonitroaniline‐DNA adducts and the roles of the enzymes (nitroreductase and acetyl CoA:arylamine N‐acetyltransferase) believed to be involved in the activation of nitroaromatic compounds. Environ. Mol. Mutagen. 59:114–122, 2018. © 2017 Wiley Periodicals, Inc. 相似文献
24.
25.
26.
TMD before and after correction of dentofacial deformities by orthodontic and orthognathic treatment
C. Abrahamsson T. Henrikson M. Nilner B. Sunzel L. Bondemark EC. Ekberg 《International journal of oral and maxillofacial surgery》2013,42(6):752-758
The aims of the study were to investigate the alteration of temporomandibular disorders (TMD) after correction of dentofacial deformities by orthodontic treatment in conjunction with orthognathic surgery; and to compare the frequency of TMD in patients with dentofacial deformities with an age and gender matched control group. TMD were evaluated in 121 consecutive patients (treatment group), referred for orthognathic surgery, by a questionnaire and a clinical examination. 18 months after treatment, 81% of the patients completed a follow-up examination. The control group comprised 56 age and gender matched subjects, of whom 68% presented for follow-up examination. TMD were diagnosed according to research diagnostic criteria for TMD. At baseline examination, the treatment group had a higher frequency of myofascial pain (P = .035) and arthralgia (P = .040) than the control group. At follow-up, the frequencies of myofascial pain, arthralgia and disc displacement had decreased in the treatment group (P = .050, P = .004, P = .041, respectively). The frequency of TMD was comparable in the two groups at follow-up. Patients with dentofacial deformities, corrected by orthodontic treatment in conjunction with orthognathic surgery, seem to have a positive treatment outcome in respect of TMD pain. 相似文献
27.
28.
F Jault I Gandjbakhch P Debat P Nataf J Petrie H Benhadj Amor A Pavie C Cabrol 《Archives des maladies du coeur et des vaisseaux》1989,82(11):1863-1865
The aim of deferred autotransfusion associated with the Cell-Saver system, i.e. the recovery of intraoperative blood loss, is to avoid using external homologous blood products. Transfusion-transmitted diseases and immunisation problems can be avoided: normovolumic haemodilution is an advantage in patients with coronary artery disease and economies can be made in the use of homologous blood. This technique has been in use in Professor Cabrol's department since 1987 with the help of the Blood Transfusion Centre of the Pitié Hospital. The contraindications are unstable angina, severe cardiac failure and anaemia of less than 11 g Hb at the first consultation. A review of the first 65 patients included in the protocol showed that deferred autotransfusion was well tolerated in all cases and that only 10 per cent of patients required transfusion with homologous blood. Autotransfusion associated with the Cell-Saver system is therefore a good method which should be extended to the largest possible number of patients referred for elective cardiac surgery. 相似文献
29.
A. CÖMLEKÇ S. BBEROLU O. KOZAN O. BAHÇEC O. ERGENE C. NAZLI O. KINAY G. GÜNER 《Journal of internal medicine》1997,242(6):449-454
Abstract. Comlekqi A, Biberoglu S, Kozan 0, Bahqeci 0, Ergene 0, Nazli C, Kinay 0, Guner G (Dokuz Eylul University, Medical School, Inciralti, Izmir, Turkey). Correlation between serum lipoprotein(a) and angio-graphic coronary artery disease in non-insulin-dependent diabetes mellitus. J Intern Med 1997; 242:449-54.
Objectives: To examine the impact of diabetic state on the concentrations of lipoprotein(a) [Lp(a)] in patients with non-insulin-dependent diabetes mellitus (NIDDM) and the correlation between angiographic coronary artery disease (CAD) and serum Lp(a) concentrations in NIDDM.
Design: In this cross-sectional study of 26 patients with NIDDM and 19 nondiabetic sex- and agematched patients who underwent coronary angiography, CAD was assessed visually using coronary artery score (CAS), and plasma Lp(a) was measured by an enzyme-linked immunosorbent assay.
Setting: The study was performed in an internal medicine clinic at a university hospital.
Subjects: Twenty-six age- and sex-matched patients with NIDDM and 19 control patients without diabetes.
Results: There was no significant difference between the Lp(a) concentrations of patientswith NIDDM and nondiabetic subjects (P > 0.05). When patients with NIDDM were stratified by absence or presence of CAD, patients with CAD had higher levels of Lp(a) (P < 0.05). However, there was no significant correlation between the concentrations of Lp(a) and CAS (P > 0.05).
Conclusions: Diabetic state does not have any impact on Lp(a) concentrations. Lp(a) excess seems to be atherogenic in patients with NIDDM as shown in nondiabetic patients in previous studies. Although diabetic patients with CAD have higher Lp(a) concentrations than the diabetic patients without CAD, Lp(a) levels were not correlated with CAS. 相似文献
Objectives: To examine the impact of diabetic state on the concentrations of lipoprotein(a) [Lp(a)] in patients with non-insulin-dependent diabetes mellitus (NIDDM) and the correlation between angiographic coronary artery disease (CAD) and serum Lp(a) concentrations in NIDDM.
Design: In this cross-sectional study of 26 patients with NIDDM and 19 nondiabetic sex- and agematched patients who underwent coronary angiography, CAD was assessed visually using coronary artery score (CAS), and plasma Lp(a) was measured by an enzyme-linked immunosorbent assay.
Setting: The study was performed in an internal medicine clinic at a university hospital.
Subjects: Twenty-six age- and sex-matched patients with NIDDM and 19 control patients without diabetes.
Results: There was no significant difference between the Lp(a) concentrations of patientswith NIDDM and nondiabetic subjects (P > 0.05). When patients with NIDDM were stratified by absence or presence of CAD, patients with CAD had higher levels of Lp(a) (P < 0.05). However, there was no significant correlation between the concentrations of Lp(a) and CAS (P > 0.05).
Conclusions: Diabetic state does not have any impact on Lp(a) concentrations. Lp(a) excess seems to be atherogenic in patients with NIDDM as shown in nondiabetic patients in previous studies. Although diabetic patients with CAD have higher Lp(a) concentrations than the diabetic patients without CAD, Lp(a) levels were not correlated with CAS. 相似文献
30.
Alexandra Thompson Trent Petrie Bailey Tackett Kayla Balcom C. Edward Watkins 《Journal of Science and Medicine in Sport》2021,24(6):531-535
ObjectivesFemale athletes experience eating disorders (EDs) at clinical, and subclinical, levels; most studies have determined point-prevalence rates through cross-sectional methodologies. To date, few studies have examined the long-term stability of EDs in female athletes; none extend into retirement.DesignA longitudinal investigation of ED classification (i.e., Clinical ED, Subclinical ED, Healthy) and weight control behaviors (e.g., vomiting, laxative use) from when athletes actively competed (T1) into their retirement (T2).MethodsParticipants included U.S. female athletes (N = 193) who were collegiate competitors (T1) and eventually were retired from their collegiate sports six years later (T2).ResultsAt T2, athletes were classified as Healthy (69.9%), Subclinical ED (26.9%), and Clinical ED (3.1%). Overall percentage of Subclinical EDs increased from 18.7% (T1) to 26.9% (T2); 52.8% of T1 Subclinical ED athletes continued to meet criteria for either Subclinical or Clinical ED at T2. Of the 13 Clinical ED athletes at T1, six (46.2%) continued to meet criteria for either a subclinical or clinical ED at T2. Though exercising (2+ hours/day; n = 8, 4.1%) and dieting/fasting (4+ times/year; n = 14, 7.3%) were the most frequently used weight control behaviors at T2, rates were substantially lower than at T1.ConclusionsRetirement does not result in immediate remittance of eating concerns among female athletes; many continue or develop Subclinical and Clinical ED symptoms. Thus, addressing healthy body image and nutrition when athletes are competing is imperative to assist prevention and intervention efforts that may alleviate ED symptoms as athletes transition from sport. 相似文献